| Jessica Niakan Beyda, MD | |
|
111 E 210th St, Bronx, NY 10467-2401 | |
| (718) 920-6573 | |
| Not Available |
| Full Name | Jessica Niakan Beyda |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 11 Years |
| Location | 111 E 210th St, Bronx, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811232846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 269064-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital - The Heart Center | Roslyn, NY | Hospital |
| Good Samaritan Hospital Medical Center | West islip, NY | Hospital |
| St Charles Hospital | Port jefferson, NY | Hospital |
| John T Mather Memorial Hospital Of Port Jefferson | Port jefferson, NY | Hospital |
| St Catherine Of Siena Hospital | Smithtown, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathology And Laboratory Consultants Of Long Island Pllc | 0244222115 | 19 |
| Main Street Medical Services Pllc | 2466678289 | 2 |
| Daniel S Reich Md Gastroenterology Pllc | 2668615212 | 3 |
| Precision Digestive Care, Pc | 5092077990 | 2 |
News Archive
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The University Hospital of Zurich has become the first medical center in the world to commence treating cancer patients with the revolutionary TrueBeam system from Varian Medical Systems, a new platform for image-guided radiotherapy and radiosurgery that was designed from the ground up to treat a moving target with unprecedented speed and precision.
Forty per cent of community pharmacists have dispensed an off-label drug to a child in the last month, according to research published in the July issue of the British Journal of Clinical Pharmacology.
The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.
› Verified 8 days ago
| Entity Name | Pathology And Laboratory Consultants Of Long Island Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144212747 PECOS PAC ID: 0244222115 Enrollment ID: O20040331001217 |
News Archive
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The University Hospital of Zurich has become the first medical center in the world to commence treating cancer patients with the revolutionary TrueBeam system from Varian Medical Systems, a new platform for image-guided radiotherapy and radiosurgery that was designed from the ground up to treat a moving target with unprecedented speed and precision.
Forty per cent of community pharmacists have dispensed an off-label drug to a child in the last month, according to research published in the July issue of the British Journal of Clinical Pharmacology.
The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.
› Verified 8 days ago
| Entity Name | Fpa Hospital Based |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629319413 PECOS PAC ID: 4789826694 Enrollment ID: O20130806000185 |
News Archive
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The University Hospital of Zurich has become the first medical center in the world to commence treating cancer patients with the revolutionary TrueBeam system from Varian Medical Systems, a new platform for image-guided radiotherapy and radiosurgery that was designed from the ground up to treat a moving target with unprecedented speed and precision.
Forty per cent of community pharmacists have dispensed an off-label drug to a child in the last month, according to research published in the July issue of the British Journal of Clinical Pharmacology.
The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.
› Verified 8 days ago
| Entity Name | Daniel S Reich Md Gastroenterology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922446178 PECOS PAC ID: 2668615212 Enrollment ID: O20130829000178 |
News Archive
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The University Hospital of Zurich has become the first medical center in the world to commence treating cancer patients with the revolutionary TrueBeam system from Varian Medical Systems, a new platform for image-guided radiotherapy and radiosurgery that was designed from the ground up to treat a moving target with unprecedented speed and precision.
Forty per cent of community pharmacists have dispensed an off-label drug to a child in the last month, according to research published in the July issue of the British Journal of Clinical Pharmacology.
The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.
› Verified 8 days ago
| Entity Name | Main Street Medical Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346650108 PECOS PAC ID: 2466678289 Enrollment ID: O20140730002317 |
News Archive
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The University Hospital of Zurich has become the first medical center in the world to commence treating cancer patients with the revolutionary TrueBeam system from Varian Medical Systems, a new platform for image-guided radiotherapy and radiosurgery that was designed from the ground up to treat a moving target with unprecedented speed and precision.
Forty per cent of community pharmacists have dispensed an off-label drug to a child in the last month, according to research published in the July issue of the British Journal of Clinical Pharmacology.
The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.
› Verified 8 days ago
| Entity Name | Precision Digestive Care, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306350483 PECOS PAC ID: 5092077990 Enrollment ID: O20180312001837 |
News Archive
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The University Hospital of Zurich has become the first medical center in the world to commence treating cancer patients with the revolutionary TrueBeam system from Varian Medical Systems, a new platform for image-guided radiotherapy and radiosurgery that was designed from the ground up to treat a moving target with unprecedented speed and precision.
Forty per cent of community pharmacists have dispensed an off-label drug to a child in the last month, according to research published in the July issue of the British Journal of Clinical Pharmacology.
The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Niakan Beyda, MD 111 E 210th St, Bronx, NY 10467-2401 Ph: () - | Jessica Niakan Beyda, MD 111 E 210th St, Bronx, NY 10467-2401 Ph: (718) 920-6573 |
News Archive
LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The University Hospital of Zurich has become the first medical center in the world to commence treating cancer patients with the revolutionary TrueBeam system from Varian Medical Systems, a new platform for image-guided radiotherapy and radiosurgery that was designed from the ground up to treat a moving target with unprecedented speed and precision.
Forty per cent of community pharmacists have dispensed an off-label drug to a child in the last month, according to research published in the July issue of the British Journal of Clinical Pharmacology.
The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.
› Verified 8 days ago
Dr. Stephen Michael Factor, Pathology Medicare: Medicare Enrolled Practice Location: 1400 Pelham Pkwy S, Bronx, NY 10461 Phone: 718-918-3060 Fax: 718-918-4469 | |
Dr. Nichelle T Simmons, Pathology Medicare: Medicare Enrolled Practice Location: 1400 Pelham Pkwy S, Bronx, NY 10461 Phone: 718-918-3060 Fax: 718-918-4469 | |
Kathryn E Tanaka, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 111 E 210th St, Surgical Pathology N-4, Bronx, NY 10467 Phone: 718-920-4976 Fax: 718-920-7611 | |
Dr. Mark Everett Smethurst, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 130 W Kingsbridge Rd, Bronx, NY 10468 Phone: 718-584-9000 Fax: 718-741-4615 | |
Kathie Schlesinger, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Mmc - Dept. Of Pathology, 111 East 210th Street, Bronx, NY 10467 Phone: 718-920-6329 | |
Sandra E Reznik, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Weiler - Dept. Of Pathology, 1825 Eastchester Road, 3rd Fl., Bronx, NY 10461 Phone: 718-904-2861 | |
Dr. Adam Jay Gersten, MD Pathology Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Foreman 4 - Department Of Pathology, Bronx, NY 10467 Phone: 718-920-4976 |